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Antibacterial peptide acylation, which mimics the structure of
the natural lipopeptide polymyxin B, increases antimicrobial and
endotoxin-neutralizing activities. The interaction of the lactofer-
ricin-derived peptide LF11 and its N-terminally acylated ana-
logue, lauryl-LF11, with different chemotypes of bacterial lipo-
polysaccharide (LPS Re, Ra and smooth S form) was investigated
by biophysical means and was related to the peptides’ biological
activities. Both peptides exhibit high antibacterial activity against
the three strains of Salmonella enterica differing in the LPS
chemotype. Lauryl-LF11 has one order of magnitude higher activ-
ity against Re-type, but activity against Ra- and S-type bacteria
is comparable with that of LF11. The alkyl derivative peptide
lauryl-LF11 shows a much stronger inhibition of the LPS-induced
cytokine induction in human mononuclear cells than LF11.
Although peptide–LPS interaction is essentially of electrostatic
nature, the lauryl-modified peptide displays a strong hydrophobic
component. Such a feature might then explain the fact that
saturation of the peptide binding takes place at a much lower
peptide/LPS ratio for LF11 than for lauryl-LF11, and that an over-
compensation of the negative LPS backbone charges is observed
for lauryl-LF11. The influence of LF11 on the gel-to-liquid-
crystalline phase-transition of LPS is negligible for LPS Re, but
clearly fluidizing for LPS Ra. In contrast, lauryl-LF11 causes a
cholesterol-like effect in the two chemotypes, fluidizing in the gel
and rigidifying of the hydrocarbon chains in the liquid-crystalline
phase. Both peptides convert the mixed unilamellar/non-lamellar
aggregate structure of lipid A, the ‘endotoxic principle’ of LPS,
into a multilamellar one. These data contribute to the under-
standing of the mechanisms of the peptide-mediated neutral-
ization of endotoxin and effect of lipid modification of peptides.
Key words: antimicrobial peptide, antisepsis, endotoxin, hydro-
phobic extension, lactoferricin, lipopolysaccharide (LPS).
INTRODUCTION
Despite the existence of broad-range antibiotics, septic shock
resulting from bacterial infection remains a frequent cause of
death, particularly in intensive care units. One main therapeutic
approach to combat infectious diseases is the use of the naturally
occurring protein lactoferrin (LF) and its N-terminal fragment
released in vivo after cleavage by pepsin, termed lactoferricin [1].
LF is an iron-binding protein, a major component of secondary
granules of neutrophils, which is released from these cells during
inflammation [2]. Lactoferricin consists of the region between
amino acid residues 17 and 41 for bovine, and 1 and 45 for
human, LF [3], and inhibits the growth of a broad range of bacteria
and other pathogens. Its mode of action is assumed to consist in
membrane perturbation [4].
In the case of Gram-negative bacteria, LPS (lipopolysaccharide;
endotoxin) from the outer leaflet of the outer membrane is the
first target of all antibiotics. LPS consists of a lipid part, termed
lipid A, anchoring the molecule into the membrane, and a cova-
lently linked oligo- or poly-saccharide directed outwards [5].
Lipid A is the minimal biological active unit of LPS and is thus
called the ‘endotoxic principle’ of LPS. Since LPS is essential for
the survival of Gram-negative bacteria, its release due to antibiotic
attack leads to bacterial death. However, isolated endotoxin
essentially contributes to the inflammation process by interacting
with cellular membranes of immune cells, such as mononu-
clear cells, leading to the secretion of cytokines such as inter-
leukins and TNFα (tumour necrosis factor α). Depending on the
location and the amounts of LPS liberated, the outcome may
be either less severe or leading to the septic shock syndrome,
often with fatal consequences [6]. Thus, besides eradication of
bacteria, an effective neutralization of isolated LPS is of utmost
importance in the field of sepsis research. The N-terminal part
of lactoferricin is effective in neutralizing LPS with a similar
effectiveness as polymyxin B [7], and, in particular, a stretch
of 11 amino acid residues within lactoferricin (residues 21–31)
exhibited antibacterial and endotoxin-neutralizing activities [4,8].
C-terminal linkage of acyl chains to this peptide significantly
enhanced the LPS-binding capacity. Most effective was the
12-carbon-unit acyl derivative [8]. We selected this sequence, now
termed LF11, as a basis for the development of endotoxin-
neutralizing and antibacterial drugs. In the present paper, we
report the results of biophysical and biochemical investigations
into the interaction between LF11 and its N-terminally linked
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12-carbon-units acyl derivative (lauryl-LF11) and LPS of varying
sugar length. This comprises the characterization of the endotoxin
binding to the peptide, as well as the activities in biological tests.
MATERIALS AND METHODS
Bacterial strains
Bacterial strains used were wild-type or LPS-mutant strains
of Salmonella enterica (serovar Minnesota) with smooth-form
LPS (S-form, wild-type), strain R60 (LPS Ra), and strain R595
(LPS Re). Bacteria were grown overnight in LB (Luria–Bertani)
medium, composed of 1% tryptone, 0.5% yeast extract and 1%
NaCl, under constant shaking at 37 ◦C, and subsequently inocul-
ated in the same medium to reach the mid-exponential phase.
Lipids
Bacteria grown at 37 ◦C were phenol-extracted, treated with
RNase, DNase and proteinase, dialysed, and freeze-dried. From
this freeze-dried sample, LPS from rough mutants Re (strain
R595) and Ra (strain R60) from S. enterica were extracted by
the phenol/chloroform/light petroleum method [9], purified, and
freeze-dried. Smooth-form LPS from S. enterica was extracted
according to the phenol/water procedure [10]. Free lipid A was
isolated by acetate buffer treatment of LPS R595. After isolation,
the resulting lipid A was purified and converted into its tri-
ethylamine salt.
Peptides
The peptides LF11 [FQWQRNIRKVR-NH2, MM (molecular
mass) = 1529.8 Da] and lauryl-LF11 [CH3-(CH2)10-CO-NH-
FQWQRNIRKVR-NH2, MM = 1712.1 Da] were purchased from
NeoMPS (San Diego, CA, U.S.A.). The purities were > 96%
as determined by RP (reverse-phase)-HPLC and MS. Melittin
(HPLC grade, MM = 2846.5 Da) was purchased as synthetic pep-
tide from Sigma (Deisenhofen, Germany) and used without
further purification.
Preparation of endotoxin aggregates
LPS or lipid A was solubilized in the respective buffer (lipid
concentration 1–10 mM, depending on the applied technique),
extensively vortex-mixed, sonicated for 30 min, and subjected to
several temperature cycles between 20 and 60 ◦C. Finally, the lipid
suspension was incubated at 4 ◦C for at least 12 h before use.
Assay for antibacterial activity
Peptides were dissolved at a concentration of 100 µg/ml (LF11
and lauryl-LF11) or up to 25 µg/ml (melittin) in 20 mM Hepes,
pH 7.0, and 180 µl of this solution filled the first well of a
microtitre plate. For a 2-fold serial dilution, each 90 µl was
transferred to the next well filled with the same volume of buffer.
Subsequently, a suspension of exponential-phase bacteria in LB
was added (10 µl, containing 104 colony forming units) to the
peptide solution (90 µl). The plates were incubated overnight in
a wet chamber at 37 ◦C under constant shaking, and bacterial
growth was monitored by measuring the attenuance at 620 nm in
a microtitre-plate reader (Rainbow, Tecan, Crailsham, Germany).
The MIC (minimal inhibitory concentration) was defined as the
lowest peptide concentration, where no bacterial growth was
measurable. Portions of each well (10 µl) were diluted with
90 µl of Hepes buffer, plated out in duplicate on LB-agar plates,
incubated overnight at 37 ◦C, and bacterial colonies were counted.
The MBC (minimal bactericidal concentration) was defined as the
peptide concentration where no colony growth was observed. Ex-
periments were performed at least twice in duplicates.
Stimulation of human MNCs (mononuclear cells) by LPS
MNCs were isolated from heparinized blood of healthy donors as
described previously [11]. The cells were resuspended in medium
(RPMI 1640) and their number was equilibrated at 5×106 cells/
ml. For stimulation, 200 µl of MNC suspension (1×106 cells) was
transferred into each well of a 96-well culture plate. LPS and
peptide/LPS mixtures were incubated for 30 min at 37 ◦C,
and added to the cultures at 20 µl per well. The cultures were incu-
bated for 4 h at 37 ◦C under 5%CO2. Supernatants were collected
after centrifugation of the culture plates for 10 min at 400 g and
stored at − 20 ◦C until determination of TNFα content. Immuno-
logical determination of TNFα was carried out in a sandwich
ELISA using a monoclonal antibody against TNF (clone 6b from
Intex AG, Muttenz, Switzerland) and has been described in detail
previously [11].
Assay for haemolytic activity
RBCs (red blood cells) were obtained from citrated human blood
by centrifugation (1500 g, 10 min), washed three times with
isotonic 20 mM phosphate/NaCl buffer (pH 7.4), and suspended
in the same buffer at a concentration equivalent to 5% of the
normal haematocrit. Aliquots of 40 µl of this RBC suspension
were added to 0.96 ml of peptide dilutions prepared in the same
isotonic phosphate solution, incubated at 37 ◦C for 30 min and
centrifuged (1500 g, 10 min). The supernatants were analysed
spectrophotometrically (absorbance at 543 nm) for haemoglobin,
and results are expressed as the percentage released with respect to
sonicated controls (100% release) or controls processed without
peptides (0% release) [12].
Cytotoxicity assay
Cytotoxicity was assayed on HeLa cells by two independent
methods, the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
2H-tetrazolium bromide]-PMS (phenazine methosulphate) assay,
which assesses the performance of the respiratory chain by the
reduction of a tetrazolium base compound to a blue formazan
product [13], and the Trypan Blue exclusion test, which assesses
alterations in membrane integrity as determined by the uptake of
this dye by dead cells [14]. In both protocols, cells were grown
in DMEM (Dulbecco’s modified Eagle’s medium) (Invitrogen
S.A., Barcelona, Spain) to a density of 5 × 105 cells/ml and
distributed (100 µl or 50 000 cells/well) in 96-well (flat-bottom)
polystyrene plates. Plates were incubated for 16 h at 37 ◦C
in a 5% CO2 atmosphere, then supplemented with increasing
amounts of peptides diluted in 20 mM Hepes, pH 7.2, and incu-
bation was carried on for 20 h under the same conditions.
Preliminary experiments showed that these conditions increased
the sensitivity of the methods, while keeping spontaneous cell
decay at background levels. After this time, 0.22-µm-filtered
MTT (Promega Biosciences, San Luis Obispo, CA, U.S.A.) and
PMS (Sigma Chemical Co., St. Louis, MO, U.S.A.) solutions (at
2 and 0.92 mg/ml respectively) in Dulbecco’s PBS (2.68 mM
KCl, 137 mM NaCl, 1.47 mM KH2PO4, 8.1 mM Na2HPO4,
0.9 mM CaCl2 and 0.5 mM MgCl2, pH 6.5) were mixed in a
20:1 proportion in the dark, and 25 µl of the mixture was added
to each well. After 30 min of incubation at 37 ◦C in a 5% CO2
atmosphere, the contents of the wells were mixed with gentle
rotation with 100 µl of 40 mM HCl in propan-2-ol to solubilize
any blue formazan crystals, and this product was measured
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photometrically at 550 nm in a Tittertek Multiscan (Flow Labora-
tories, McLean, VA, U.S.A.) plate reader. Alternatively, an aliquot
of the cells was taken (before MTT-PMS addition), mixed with
an equal volume of 0.4% (w/v) Trypan Blue (Sigma), dispensed
into the chamber of a Neubauer haemocytometer, and at least
100 cells were examined for dye uptake under a phase-contrast
microscope [14]. In both methods, controls were cells incubated
without peptide (0% cytotoxicity reference values) or with 10 µl
of DMSO (100% cell death reference values).
FTIR (Fourier transform IR) spectroscopy
The IR spectroscopic measurements were performed on an IFS-55
spectrometer (Bruker, Karlsruhe, Germany). Samples, dissolved
in 20 mM Hepes, pH 7.0, were placed in a CaF2 cuvette with
a 12.5 µm Teflon spacer. Measurements were performed at the
intrinsic instrument temperature (26 ◦C), or, if indicated, temper-
ature-scans were performed automatically between 10 and 70 ◦C
with a heating rate of 0.6 ◦C/min. Every 3 ◦C, 50 interferograms
were accumulated, apodized, Fourier-transformed and converted
into absorbance spectra. For strong absorption bands, the band
parameters (peak position, band width and intensity) were evalu-
ated from the original spectra, if necessary after subtraction of the
strong water bands.
DSC (differential scanning calorimetry)
Endotoxin dispersions (1 mg/ml) were prepared as described
above by dissolving a known amount of LPS in 10 mM phosphate
buffer, pH 6.8, and the sample was degassed for 10 min. Different
amounts of peptides were mixed with the endotoxin dispersion
and investigated by DSC using the VP DSC unit from MicroCal
Inc. (Northampton, MA, U.S.A.). The sample cell was filled with
the endotoxin preparation, whereas the reference cell was filled
with buffer. Heating and cooling curves were measured in the
temperature interval 10–90 ◦C. Three consecutive heating and
cooling scans were performed at a scanning rate of 1 ◦C/min [15].
The phase-transition enthalpy was calculated as the integral
intensity of the heat capacity curve. The data were analysed using
the appropriate Origin software as described previously [15].
45Ca displacement
To investigate the ability of the peptides to displace divalent Ca2+
cations from LPS monolayers, a subphase with 12.5 µM
Ca2+ doped with radioactive 45Ca2+ (at a final activity of 250 Bq/
ml; Amersham-Buchler, Braunschweig, Germany) and 5 mM
Hepes, pH 7.0, were used. The experiments were performed
as described in [16] using an LPS R595 monolayer (10 nmol/
112 cm2). The peptides were added to the subphase (60 ml)
in different concentrations, and the equilibrium β-counting
rates were recorded. The relative 45Ca concentration was
calculated from the equation Irel = (Ipep − Isub)/(Imono − Isub), with
Irel = relative 45Ca intensity, Isub, Imono and Ipep, the β-intensities
of the pure subphase, after spreading of the monolayer and after
peptide addition respectively.
Zeta potential
Zeta potentials were determined with a Zeta-Sizer 4 (Malvern
Instruments, Herrsching, Germany) at a scattering angle of 90 ◦
from the electrophoretic mobility by laser-Doppler anemometry
as described previously [11]. The zeta potential was calculated
according to the Helmholtz–Smoluchovski equation from the mo-
bility of the aggregates in a driving electric field of 19.2 V · cm−1.
Endotoxin aggregates (0.1 mM) and peptide stock solutions
(0.5 mM) were prepared in 10 mM Tris/HCl and 2 mM CsCl,
pH 7.0, which was found to give the most reproducible results.
X-ray diffraction
X-ray diffraction measurements were performed at the European
Molecular Biology Laboratory (EMBL) outstation at the
Hamburg synchrotron radiation facility HASYLAB using the
double-focusing monochromator-mirror camera X33 [17]. Diff-
raction patterns in the range of the scattering vector 0.07 < s <
1 nm−1 (s = 2 sin θ /λ; 2θ , scattering angle and λ, the wave-
length = 0.15 nm) were recorded at various temperatures with
exposure times of 2 or 3 min using a linear detector with delay
line readout [18]. The s-axis was calibrated with tripalmitin which
has a periodicity of 4.06 nm at room temperature (22 ◦C). Details
of the data acquisition and evaluation system can be found else-
where [19]. The diffraction patterns were evaluated as described
previously [11], assigning the spacing ratios of the main scattering
maxima to defined three-dimensional structures. The lamellar and
cubic structures are most relevant here. They are characterized by
the following features: (i) lamellar: the reflections are grouped in
equidistant ratios, i.e. 1, 1/2, 1/3, 1/4 etc., of the lamellar repeat
distance dl; (ii) cubic: the different space groups of these non-
lamellar three-dimensional structures differ in the ratio of their
spacings. The relation between reciprocal spacing shkl = 1/dhkl and
lattice constant a is shkl = [(h2 + k2 + l2)/a ]1/2 , where h, k and l are
the Miller indices of the corresponding set of plane.
RESULTS
Antibacterial, cytotoxic and haemolytic activities of peptides
In a first step, the antibacterial activity of the two peptides LF11
and lauryl-LF11 against bacteria with LPS of different sugar-chain
lengths were determined, with the well characterized peptide
melittin from bee venom as a reference (Figure 1). All peptides
have the highest activity against S. enterica (strain R595) whose
outer membrane outer leaflet consists of deep rough mutant LPS
Re. In particular, lauryl-LF11 and melittin exhibited comparable
activity, which was considerably higher than for LF11. For
bacteria with a LPS chemotype of much longer sugar chains (Ra
and S-form), corresponding to a higher hydrophilicity of their
LPS, the antibacterial activities of the peptides are significantly
lower than for bacteria expressing LPS Re, and the activities
of LF11 and its acylated derivative were the same. In contrast
with their antibacterial activity, both peptides are non-cytotoxic
to HeLa cells at concentrations up to 500 µg/ml. However,
the acylated peptide, but not LF11, showed haemolytic activity
comparable with that of melittin at concentrations above the MICs
(results not shown).
Inhibition of LPS-induced cell activation by peptides
The inhibition of the LPS-induced induction of TNFα in human
MNCs due to peptide binding is shown in Figure 2. For all LPS,
lauryl-LF11 inhibits the cytokine induction at a concentration
between 20 and 60 nM, whereas LF11 inhibits only LPS Re
effectively, but at a 3-fold higher dose than lauryl-LF11.
Ca-displacement from LPS monolayers
The outer membrane of LPS of Gram-negative bacteria is stabi-
lized by divalent cations. Disruption of the bacterial membrane
integrity can be accomplished either by removal of those ions by
complexation or by their replacement with polycations such as
cationic peptides. The ability of the peptides to displace 45Ca
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Figure 1 Antibacterial activity of lactoferricin-derived peptides LF11 ()
and lauryl-LF11 (), compared to synthetic bee venom melittin () against
S. enterica serovar Minnesota strains with variation in the LPS carbohydrate
structures
(A) Strain R595 (LPS Re); (B) strain R60 (LPS Ra); (C) wild-type (S-form LPS).
cations from the backbone of an LPS Re monolayer at the
air/water interface was investigated (Figure 3). Here, LF11 has a
slightly higher capacity than lauryl-LF11 to displace LPS-bound
calcium. Both peptides displaced all cations at a peptide/LPS
ratio of approx. 3. Therefore higher antimicrobial and endotoxin-
neutralizing activities of the acylated form of the peptide are not
due to the replacement of cations stabilizing the LPS layer.
Compensation of the accessible surface charges of LPS aggregates
(zeta potential) by the peptides
As a measure for the accessible surface charges in LPS aggregates,
the zeta potential was determined for LPS Re and Ra by
measuring their electrophoretic mobility at different peptide
concentrations (Figure 4). For LPS Re with a short sugar chain,
LF11 compensates the surface charges of LPS at a peptide/LPS
molar ratio of 2. For LPS Ra, the charge is compensated to −5 mV
at a peptide/LPS molar ratio of 4. Complete compensation, extra-
polated from the curve, may be reached at a peptide/LPS molar
ratio of approx. 5–6. In contrast, lauryl-LF11 overcompensates
the surface charges of LPS Re and Ra, indicating that, besides
electrostatic interaction, a further process, hydrophobic inter-
action, takes place. The charge compensation (zero zeta potential)
is reached for LPS Re at a molar peptide/LPS ratio below 1,
whereas this ratio is approx. 2.5 for LPS Ra.
Figure 2 Concentration-dependent inhibition of the biological activity of
various LPS by synthetic peptides
LF11 () and lauryl-LF11 () were incubated with 0.5 ng/ml LPS Re (A), 0.5 ng/ml LPS Ra
(B) or 1 ng/ml S-form LPS (C) at the indicated peptide concentrations. The mixtures were used
to activate human MNCs. As a marker of LPS-induced cell activation, the production of the
cytokine TNFα was determined by ELISA.
Figure 3 Displacement of 45Ca from LPS Re monolayers by cationic
peptides
LF11 () and lauryl-LF11 () were injected in the subphase under an LPS Re monolayer
saturated with 45Ca. Peptide binding resulted in the displacement of calcium accompanied by a
decrease in radioactivity.
Peptide–LPS-binding enthalpies
For the elucidation of the stoichiometry of peptide–LPS binding,
ITC (isothermal titration calorimetry) performed at 37 ◦C was
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Figure 4 Dependence of zeta potential of LPS preparations (A, LPS Re; B,
LPS Ra) on different peptide/LPS molar ratios
LF11 () and lauryl-LF11 () were titrated against LPS suspensions and the zeta potential
was determined from the electrophoretic mobility analysed by laser-Doppler anemometry. Note
the charge overcompensation for lauryl-LF11.
applied. The results of LF11 binding to three LPS chemotypes
are shown in Figure 5(A), those of lauryl-LF11 binding to LPS are
shown in Figure 5(B). Clearly, for both peptides and all LPS
chemotypes, only exothermic (negative enthalpy change) pro-
cesses are observed, indicating dominant electrostatic interac-
tions. Furthermore, differences in binding saturation are observed
which may be correlated with the length of the LPS sugar chains.
Thus, for LF11 binding to LPS, saturation is observed at an
LF11/LPS Re molar ratio of approx. 0.8, and for the two LPS with
longer sugar chains, the ratio is between 1.3 and 1.7. Similarly,
the binding of lauryl-LF11 to the LPS is saturated at a lauryl-
LF11/LPS molar ratio of approx. 1.25 for LPS Re, and above
2.2–2.5 for LPS Ra and S-form LPS. Moreover, the binding of
S-form LPS is biphasic, starting with a plateau at approx. −20 to
−40 kJ/mol at lower peptide concentrations, and a maximum at
approx. −50 to −60 kJ/mol at a lauryl-LF11/LPS molar ratio of
between 1.0 and 1.5.
Influence of the peptides on the phase behaviour of LPS acyl chains
The gel-to-liquid-crystalline phase-transition of the acyl chains
of LPS in the presence of different amounts of peptides was
monitored by plotting the peak positions of the symmetric
stretching vibration νs(CH2) against temperature (Figure 6). LF11
causes only a very slight change in the transition curve of LPS
Re, for which the phase-transition temperature (Tc) lies at approx.
31 ◦C. In contrast with LPS Ra, LF11 induces a clear increase in
the wavenumbers, corresponding to the fluidization of the acyl
chains. The action of lauryl-LF11 is similar for both LPS, a
fluidization occurs in particular in the gel phase, which is strong
for LPS Re and weaker for LPS Ra.
The thermodynamic parameters of pure LPS Re as obtained
from DSC are: T c = 31.0 ◦C, half-width T1/2= 7 ◦C and phase-
transition enthalpy Hc = 39.4 kJ/mol. The presence of LF11
Figure 5 Enthalpy change of the peptide-LPS (, LPS Re; , LPS Ra;
, S-form LPS) binding reaction as a function of various peptide/LPS molar
ratios from calorimetric titration curves
(A) LF11; (B) lauryl-LF11. Positive and negativeH values indicate endothermic and exothermic
reactions respectively.
induces a 1–2 ◦C increase in T c, whereas the phase-transition
enthalpy remains unchanged (Hc ∼ 39 +− 2 kJ/mol). A slight
decrease in T c of 1–2 ◦C and a slight decrease in Hc of ∼10–
15% are observed for the lauryl-LF11/LPS Re mixtures (results
not shown). The thermodynamic parameters of the pure LPS Ra
are determined as: T c = 36.2 ◦C, T1/2=11 ◦C and Hc=19 kJ/
mol. The presence of LF11 induces a shift in the maximum of the
heat-capacity curve to lower temperature (Figure 7A). At an
equimolar LF11/LPS Ra ratio, Tc is lowered to 33.0 ◦C, indicating
a destabilization of the gel phase. Additionally, a large decrease in
the phase-transition enthalpy is observed. Compared with Hc
of the pure endotoxin, Hc of an equimolar LF11/LPS Ra mixture
is decreased by more than 60%. This can be interpreted as a
strong decrease in the van der Waals interactions between the
hydrophobic acyl chains of the LPS Ra in the presence of an
equimolar peptide/LPS mixture.
The synthetic peptide lauryl-LF11 also induces a considerable
decrease in the phase-transition enthalpy of the gel-to-liquid-
crystalline phase-transition of LPS Ra. However, only a marginal
T c shift is observed for the equimolar system from 36.1 ◦C (pure
LPS Ra) to 35.7 ◦C (Figure 7B). This is in accordance with the
FTIR data.
Influence of the peptides on the LPS-aggregate structure
Synchrotron radiation X-ray diffraction was used to investigate
the aggregate structure of lipid A (as the ‘endotoxic principle’ of
LPS) in the absence and presence of the peptides (Figure 8). Pure
lipid A adopts a mixed cubic/unilamellar structure in accordance
with earlier results [20], which can be deduced from the broad
scattering intensity maximum between 0.1 and 0.4 nm−1, and
some weak reflections superimposed (Figure 8A). In the presence
of the peptides, the diffraction patterns change with small, but
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Figure 6 Phase-transition behaviour of LPS Re and LPS Ra in the presence of LF11 and lauryl-LF11, monitored over the peak position of the symmetric
stretching vibration of the methylene groups of LPS acyl chains at different LPS/peptide molar ratios
In the gel (β) phase of the acyl chains, the peak lies at approx. 2850 cm−1; in the liquid-crystalline (α) phase, the peak lies at approx. 2852.5 cm−1.
Figure 7 Heat-capacity curves, Cpdiff, against temperature of various LPS
Ra/peptide mixtures from DSC scans
(A) LF11; (B) lauryl-LF11.
sharp, equidistant reflections (e.g. 5.35 nm and 2.68 nm for lipid
A/LF11; Figure 8B) corresponding to multilamellar stacks.
DISCUSSION
LF is a multifunctional protein with antibacterial, antiviral, an-
titumour and anti-inflammatory properties [1], which are related
to a 25-amino-acid-residue N-terminal fragment called lactofer-
ricin. Bovine lactoferricin derivatives have been described which
Figure 8 Small-angle X-ray diffraction patterns of lipid A from S. enterica
(serovar Minnesota) R595 LPS Re at 90 % water content and 40 ◦C without
peptide (A) and in the presence of LF11 (B) and lauryl-LF11 (C), at
a peptide/LPS molar ratio of 10:1
were able to cross the cell walls and cytoplasmic membranes
of both Gram-negative and Gram-positive bacteria [21]. Lacto-
ferricin derivatives corresponding to the amphipathic α-helical
region of human LF disrupt outer membranes of Gram-negative
bacteria [4,22] and neutralize endotoxin in vitro and in vivo
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(LF-33; [7]). The test of various lactoferricin derivatives from milk
LF showed that many of these compounds have high antimicrobial
activity [3].
We have designed a synthetic derivative corresponding to amino
acid residues 21–31 of human lactoferricin as a starting material,
in which the isoleucine was substituted for the methionine
residue (Met27 → Ile) to increase peptide stability. Furthermore,
the peptide lauryl-LF11 was designed, since the addition of a
12-carbon-units acyl chain has been shown to enhance antibacte-
rial and LPS-binding activities of the peptide [8]. The compre-
hensive physicochemical and biological analysis of the interaction
of the peptides with LPS, as previously performed for, e.g., LF
and the antimicrobial peptide NK-2 [23,24], showed that the
introduction of the lauryl chain enhanced the antibacterial activity
against bacteria with LPS Re, but not against those with LPS
Ra and S-form (Figure 1), which have a much longer sugar chain
and, with that, reduced hydrophobicity compared with LPS Re.
Notably, the activity of LF11 against S. enterica reported in
the present paper is much more pronounced than the anti-
Escherichia coli activity of the LF(21-31) peptide described
by Chapple et al. [22], which has an almost identical primary
structure with LF11 with the exception of the methionine/isoleu-
cine substitution mentioned above. These differences in activity
are most likely based upon the C-terminal amidation of LF11,
which enhances the effective positive net charge of the peptide and
thus strengthens the interaction with negatively charged bacterial
surface.
In the TNFα-induction assay, reflecting neutralization of bio-
logical activity of LPS (Figure 2), however, lauryl-LF11 was more
active than LF11 for all LPS chemotypes. For an interpretation,
it has to be taken into account that, in bacteria, the sugar part of
LPS is directed towards the outside and represents a barrier for the
peptides solely due to steric reasons [24], which is low for the LPS
with short-sugar chains (LPS Re). In the cytokine assay, peptides
interact with LPS aggregates, and the accessibility of the binding
epitopes in the LPS backbone might be completely different. In
this context, it should be noted that the aggregation state of the
peptides may also influence its interaction with LPS and thus its
biological activities. For a lauryl-peptide, very similar to LF11,
we observed a CMC (critical micelle concentration) of 0.4 mM,
whereas for the same peptide without the lauryl moiety, the CMC
value is significantly higher than 10 mM (results not shown). Thus
aggregation effects of lauryl-LF11 have to be considered for those
assays where the peptide concentration exceeds the CMC, i.e. the
FTIR and SAXS (small-angle X-ray scattering) measurements.
Peptide binding to LPS can be interpreted, at least initially, to be
electrostatic and to result from the attraction between the positive
charges (lysine and arginine side chains) of the peptides and the
negative charges (phosphates and carboxylates) of LPS. This can
be deduced from the data of the Ca2+ replacement of LPS Re
(Figure 3), and also from the reduction of the zeta potential, lead-
ing to binding compensation of LPS Re as well as LPS Ra (Fig-
ure 4). Beyond charge compensation, however, for lauryl-LF11, a
further increase of the zeta potential with strongly positive values
is observed, i.e. for this compound, a hydrophobic interaction of
the acyl chain residue with the lipid A moiety also takes place.
This can be deduced in a similar way from the ITC curves, leading
to a biphasic behaviour for LPS Ra and S-form (Figure 5A), and
much higher values for the binding stoichiometry of lauryl-LF11
compared with those of LF11 (Figures 5A and 5B).
The differences in hydrophobicity of the two peptides also
becomes evident from the data of the phase-transition behaviour
(Figure 6): LF11 induces only a small effect on LPS Re, and, on
the other hand, lauryl-LF11 has a small effect on LPS Ra, i.e. the
more hydrophilic peptide interacts less favourably with the more
hydrophobic LPS and vice versa. The addition of LF11 to LPS
Ra leads to the fluidization of the acyl chains in the whole
temperature range, whereas addition of lauryl-LF11 to LPS Re
increases fluidization of the acyl chains in the gel phase, and
slight rigidification in the liquid crystalline phase. The latter is
also true for lauryl-LF11 on LPS Ra, and is indicative of the
cholesterol-like effect [25,26] of this lipopeptide.
Comparison of the peptide neutralization of LPS with those of
integral human LF show a considerably higher activity of the latter
on a molar scale, leading to inhibition of the TNFα-production
already at an equimolar ratio of LPS Re and LF [23]. Regarding
the high MM of LF (80000 Da), however, the activity becomes
similar at least for LPS Re and lauryl-LF11 if calculated on a mass
scale. An important consideration is the presence of two LPS-
binding sites on LF, which contributes to the co-operativity of LPS
binding [27]. A comparison of the interaction mechanism of the
protein/peptides with LPS shows that, at binding saturation of LF,
a remaining zeta potential of −10 mV is observed, in contrast
with the complete neutralization of LPS Re found in the present
study. Furthermore, also in contrast with the results obtained in
the present study for the peptides, a clear rigidification of the acyl
chains of LPS, connected with an increase in the phase transition
temperature Tc, due to LF binding, takes place. These differences
may be indicative of large steric differences, allowing the small
peptides to interact more easily with the LPS backbone than with
the bulky protein.
Both peptides and LF behave similarly as far as the aggregate
structure is concerned, and the ‘endotoxic principle’ lipid A adopts
a multilamellar structure in their presence (Figure 8). It was found,
not only for LF and the LF-derived peptides described in the
present study, but also for other proteins and peptides, that the in-
activation of LPS is accompanied by a change of the aggregate
structure of lipid A or LPS into a multilamellar form [23,24,28–
31]. From the analysis of lipid A compounds with different
chemical structures, it was found that a non-lamellar or mixed
unilamellar/non-lamellar structure represents the active, and
a multilamellar structure the inactive form of endotoxins [32,33].
Thus highly active hexa-acyl lipid A of enterobacterial origin,
such as that from E. coli, has a cubic or a mixed unilamellar/cubic
structure, whereas agonistically inactive penta- and tetra-acyl
forms from E. coli mutants or of synthetic origin adopt
multilamellar structures [32]. The conversion observed here and
for LF is similar to that observed for binding of lysozyme [29]
and HDL (high-density lipoprotein) [28] to lipid A, but different
from binding of Hb [11] and rHSA (recombinant human serum
albumin) [34], for which the lipid A aggregate structure is changed
into another non-lamellar, probably also a cubic, structure with
a different symmetry [34]. These observations suggest that an
apparent prerequisite for neutralization of LPS by binding proteins
or peptides is the change of the aggregate structure of its lipid A
moiety into a multilamellar one. Multilamellar stacks of LPS are
facilitated by compensation of electrostatic repulsion energy be-
tween anionic polar heads of LPS due to the peptide charge
compensation. For an interpretation of the fact that the multilamel-
lar structure of a given lipid A, whether alone or after binding
to proteins, is directly correlated with endotoxic inactivity, the
following points should be considered. The endotoxin-induced
cell activation is initiated by the interaction of serum-pro-
teins such as LBP (LPS-binding protein) and membrane-bound
proteins such as CD14 with LPS [35–37], followed by transport to
transmembrane signalling molecules, such as the TLR4 (Toll-like
receptor 4)–MD-2 complex or the MaxiK ion channel [38,39] and
subsequent signalling to the cell interior. Within these complex
interaction mechanisms, the following processes seem to be of
relevance. (i) LPS aggregates are very stable. The binding energy
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of one LPS molecule with a hexa-acyl lipid A portion within
an aggregate has been determined to be lower than −400 meV
[40]. Thus, to remove LPS monomers, the binding energy of
LPS-recognition proteins such as LBP, CD14 or MD-2 to LPS
must exceed this amount. Although the dependence of binding
energy on the type of aggregate structure is unknown, it is
plausible that a monomer within multilamellar stacks is more
stably bound than, for example, within an unilamellar structure.
(ii) The accessibility of the recognition structures (epitopes)
within the LPS molecules. The eukaryotic LBPs recognize a
certain structural pattern within the LPS molecule, which is
probably a pattern in the lipid A backbone. It is obvious that the
type of aggregate structure influences this recognition process.
Thus, in multilamellar structures, most of the lipid A backbones
are hidden and not accessible to the binding proteins, in contrast
with the situation in unilamellar or cubic structures.
In summary, we significantly enhanced the endotoxin-neutra-
lizing capacity of the LF LPS-binding domain by N-terminal
linkage with a 12-carbon-units alkyl chain. We undertook a
comprehensive biophysical characterization of the interaction of
these synthetic peptides with LPS with variations in the sugar
length. The neutralization of the LPS surface charges is a prere-
quisite, but not sufficient, for an effective neutralization of the
cell-activation activity of LPS by cationic peptides. A significant
increase in inhibitory activity was observed if a hydrophobic
interaction occurs, which results in a significant overcompensa-
tion of the negative surface charge of LPS aggregates. This was
observed in the present study for lauryl-LF11 and has also been
described recently for synthetic peptides derived from NK-lysin
and LALF (Limulus anti-LPS factor) [24,31]. We suggest that the
peptide–LPS affinity must be able to compete with the LPS–LBP
interaction [24]. This is likely to be achieved by a combination of
electrostatic interactions of the positively charged amino acid side
chains of the peptides with the LPS backbone phosphate groups
and a penetration of the hydrophobic core of the LPS aggregate.
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